BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS
Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkyny...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | GIACHETTI, ANTONIO TURCONI, MARCO MONTAGNA, ERNESTO NICOLA, MASSIMO DONETTI, ARTURO UBERTI, ANNAMARIA MICHELETTI, ROSAMARIA |
description | Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA1337347C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA1337347C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA1337347C3</originalsourceid><addsrcrecordid>eNqFyrEOgjAQgGEWB6M-g_cCHbAa5uM45BJsTVtAWQgxdTJKgu8fHdxd_m_5l0mXs-nlJAX2thbDaqfst6kidLm9XGshQJICCnbSYpCWPTSey6YG9HBQVQDHxOdgHaAJeLRGfPDrZHEfH3Pc_Fwl25IDVSpOryHO03iLz_geCFOtM73PSP8_Pu2LL_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</creator><creatorcontrib>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</creatorcontrib><description>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</description><edition>6</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951017&DB=EPODOC&CC=CA&NR=1337347C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951017&DB=EPODOC&CC=CA&NR=1337347C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GIACHETTI, ANTONIO</creatorcontrib><creatorcontrib>TURCONI, MARCO</creatorcontrib><creatorcontrib>MONTAGNA, ERNESTO</creatorcontrib><creatorcontrib>NICOLA, MASSIMO</creatorcontrib><creatorcontrib>DONETTI, ARTURO</creatorcontrib><creatorcontrib>UBERTI, ANNAMARIA</creatorcontrib><creatorcontrib>MICHELETTI, ROSAMARIA</creatorcontrib><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><description>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEOgjAQgGEWB6M-g_cCHbAa5uM45BJsTVtAWQgxdTJKgu8fHdxd_m_5l0mXs-nlJAX2thbDaqfst6kidLm9XGshQJICCnbSYpCWPTSey6YG9HBQVQDHxOdgHaAJeLRGfPDrZHEfH3Pc_Fwl25IDVSpOryHO03iLz_geCFOtM73PSP8_Pu2LL_U</recordid><startdate>19951017</startdate><enddate>19951017</enddate><creator>GIACHETTI, ANTONIO</creator><creator>TURCONI, MARCO</creator><creator>MONTAGNA, ERNESTO</creator><creator>NICOLA, MASSIMO</creator><creator>DONETTI, ARTURO</creator><creator>UBERTI, ANNAMARIA</creator><creator>MICHELETTI, ROSAMARIA</creator><scope>EVB</scope></search><sort><creationdate>19951017</creationdate><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><author>GIACHETTI, ANTONIO ; TURCONI, MARCO ; MONTAGNA, ERNESTO ; NICOLA, MASSIMO ; DONETTI, ARTURO ; UBERTI, ANNAMARIA ; MICHELETTI, ROSAMARIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA1337347C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GIACHETTI, ANTONIO</creatorcontrib><creatorcontrib>TURCONI, MARCO</creatorcontrib><creatorcontrib>MONTAGNA, ERNESTO</creatorcontrib><creatorcontrib>NICOLA, MASSIMO</creatorcontrib><creatorcontrib>DONETTI, ARTURO</creatorcontrib><creatorcontrib>UBERTI, ANNAMARIA</creatorcontrib><creatorcontrib>MICHELETTI, ROSAMARIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GIACHETTI, ANTONIO</au><au>TURCONI, MARCO</au><au>MONTAGNA, ERNESTO</au><au>NICOLA, MASSIMO</au><au>DONETTI, ARTURO</au><au>UBERTI, ANNAMARIA</au><au>MICHELETTI, ROSAMARIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS</title><date>1995-10-17</date><risdate>1995</risdate><abstract>Pharmaceutically active benzimidazoline-2-oxo-1-carbo-xylic acid derivatives are described which are 5HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents, of the following formula: (I) wherein R represents a hydrogen atom, or a C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl group; R1 and R2, which may be the same or different, represent a hydrogen atom, halogen atom, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, or amino group, optionally N-mono or di-substituted by a C1-4 alkyl group, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally N-mono or di-substitu-ted by C1-4 alkyl group, cyano, C1-6 alkylsulphinyl, C1-6 alkylsulphonyl, aminosulphonyl optionally Nmono or di-substituted by a C1-4 alkyl group, aminosulphonylamino optionally N-mono or di-substituted by C1-4 alkyl group; Y is oxygen or represents N - R3 in which R3 is a hydrogen atom, a C1-6 alkyl or benzyl group, optionally substituted by one or more C1-6 alkoxy groups; A is a group selected from: (a) (b) (c) (d) wherein p is 0 or 1; r is 0, 1, 2, or 3; R4 is a hydrogen atom or a C1-4 alkyl group; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, a C3-8 cycloalkylalkyl group having 1-4 carbons in the alkyl moiety or a phenylalkyl group having 1-4 carbons in the alkyl moiety or R5 is a group of formula wherein R6 is a hydrogen atom, C1-4 alkyl or an amino group and R7 is a hydrogen atom or C1-6 alkyl group. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA1337347C |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | BENZIMIDAZOLINE-2-ONE-1-CARBOXYLIC ACID DERIVATIVES USEFUL AS 5-HT RECEPTOR ANTAGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A54%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GIACHETTI,%20ANTONIO&rft.date=1995-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA1337347C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |